BACKGROUND: Filamentous fungi are frequently recovered from respiratory cultures of individuals with CF. METHODS: A CF cohort database was utilized to determine filamentous fungal prevalence and risk factors. RESULTS: The prevalence of filamentous fungal isolation increased from 2.0% in 1997 to 28.7% in 2007. The odds of isolating filamentous fungi during a quarter was greater in CF adults [p<0.001], during chronic oral antibiotic use [p=0.002] and increased with each 10% drop in FEV(1) percent predicted [p=0.005], while inhaled corticosteroids surprisingly decreased the likelihood [p=0.012]. The direction of these effects persisted after excluding individuals with ABPA. A sub-analysis determined older age [p=0.019] and use of inhaled antibiotics [p=0.011] were independent risk factors for onset of fungal colonization. CONCLUSIONS: This study suggests that isolation of filamentous fungi in CF at JHH has increased and risk factors include older age, decreased lung function, and chronic oral antibiotics. Copyright (c) 2009 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights reserved.
BACKGROUND:Filamentous fungi are frequently recovered from respiratory cultures of individuals with CF. METHODS: A CF cohort database was utilized to determine filamentous fungal prevalence and risk factors. RESULTS: The prevalence of filamentous fungal isolation increased from 2.0% in 1997 to 28.7% in 2007. The odds of isolating filamentous fungi during a quarter was greater in CF adults [p<0.001], during chronic oral antibiotic use [p=0.002] and increased with each 10% drop in FEV(1) percent predicted [p=0.005], while inhaled corticosteroids surprisingly decreased the likelihood [p=0.012]. The direction of these effects persisted after excluding individuals with ABPA. A sub-analysis determined older age [p=0.019] and use of inhaled antibiotics [p=0.011] were independent risk factors for onset of fungal colonization. CONCLUSIONS: This study suggests that isolation of filamentous fungi in CF at JHH has increased and risk factors include older age, decreased lung function, and chronic oral antibiotics. Copyright (c) 2009 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights reserved.
Authors: J L Burns; R L Gibson; S McNamara; D Yim; J Emerson; M Rosenfeld; P Hiatt; K McCoy; R Castile; A L Smith; B W Ramsey Journal: J Infect Dis Date: 2000-12-27 Impact factor: 5.226
Authors: David A Stevens; Richard B Moss; Viswanath P Kurup; Alan P Knutsen; Paul Greenberger; Marc A Judson; David W Denning; Reto Crameri; Alan S Brody; Michael Light; Marianne Skov; William Maish; Gianni Mastella Journal: Clin Infect Dis Date: 2003-10-01 Impact factor: 9.079
Authors: J L Burns; J Emerson; J R Stapp; D L Yim; J Krzewinski; L Louden; B W Ramsey; C R Clausen Journal: Clin Infect Dis Date: 1998-07 Impact factor: 9.079
Authors: M Noni; A Katelari; G Dimopoulos; S-E Doudounakis; C Tzoumaka-Bakoula; V Spoulou Journal: Eur J Clin Microbiol Infect Dis Date: 2015-08-30 Impact factor: 3.267
Authors: Gina Hong; Kevin Alby; Sharon C W Ng; Victoria Fleck; Christina Kubrak; Ronald C Rubenstein; Daniel J Dorgan; Steven M Kawut; Denis Hadjiliadis Journal: J Cyst Fibros Date: 2019-08-21 Impact factor: 5.482
Authors: Neelkamal Chaudhary; Kausik Datta; Frederic B Askin; Janet F Staab; Kieren A Marr Journal: Am J Respir Crit Care Med Date: 2011-12-01 Impact factor: 21.405
Authors: Gina Hong; Heather B Miller; Sarah Allgood; Richard Lee; Noah Lechtzin; Sean X Zhang Journal: J Clin Microbiol Date: 2017-01-18 Impact factor: 5.948
Authors: Gina Hong; Kevin J Psoter; Mark T Jennings; Christian A Merlo; Michael P Boyle; Denis Hadjiliadis; Steven M Kawut; Noah Lechtzin Journal: J Cyst Fibros Date: 2018-02-12 Impact factor: 5.482